Publication:
Long-term prognostic value of elevated pentraxin 3 in patients undergoing primary angioplasty for ST-elevation myocardial infarction

Placeholder

Organizational Units

Program

Authors

Authors

Akgul, Ozgur
Baycan, Omer Faruk
Bulut, Umit
Somuncu, Mustafa Umut
Pusuroglu, Hamdi
Ozyilmaz, Sinem
Gul, Mehmet
Demir, Ali Riza
Yilmaz, Emre
Yazan, Serkan

Advisor

Language

Publisher

Journal Title

Journal ISSN

Volume Title

Abstract

Objectives The prognostic value of pentraxin 3 (PTX3) has been documented in patients with acute coronary syndrome. However, its long-term prognostic value in acute ST-segment elevation myocardial infarction (STEMI) remains unclear. The aim of this study was to evaluate the prognostic value of PTX3 in patients with STEMI undergoing a primary percutaneous coronary intervention (PCI).

Description

Source:

Keywords:

Keywords

Citation

Akgul O., Baycan O. F. , Bulut U., Somuncu M. U. , Pusuroglu H., Ozyilmaz S., Gul M., Demir A. R. , Yilmaz E., Yazan S., et al., -Long-term prognostic value of elevated pentraxin 3 in patients undergoing primary angioplasty for ST-elevation myocardial infarction-, CORONARY ARTERY DISEASE, cilt.26, ss.592-597, 2015

Endorsement

Review

Supplemented By

Referenced By

0

Views

0

Downloads

View PlumX Details


Sustainable Development Goals